INDGN Share Price Performance
₹0
-622.95 (-100.00%)
Price ₹0
Fair Value₹609.63
Share Pricen/a
Earnings Miss: Indegene Limited Missed EPS By 8.1% And Analysts Are Revising Their Forecasts
Feb 02
Indegene Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
INDGN Community Narratives
AN
Fair Value ₹609.63 18.0% undervalued intrinsic discount
Digital Transformation And AI Adoption Will Expand Pharma Market
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
Digital Transformation And AI Adoption Will Expand Pharma Market
Key Takeaways AI-driven digital solutions and deeper multi-year client relationships are expanding Indegene's market presence, improving revenue growth and operational efficiencies in pharma services. Strategic reinvestment and targeted acquisitions are shifting revenues toward higher-margin, technology-led offerings and expanding capabilities across new verticals and geographies.Read more
65
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
₹609.63
18.0% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
17.66% p.a.
Profit Margin
13.03%
Future PE
33.78x
Price in 2029
₹913.66
Trending Discussion
Recently Updated Narratives
AN
INDGN: Expanded Consulting Practice And Upcoming Meetings Will Support Continued Positive Momentum
Fair Value: ₹609.63 18.0% undervalued intrinsic discount
9 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Indegene Limited Key Details
About INDGN
- Founded
- 1998
- Employees
- 4158
- CEO
- WebsiteView website
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
